Charles River Laboratories International (CRL) Competitors $185.77 +3.62 (+1.99%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CRL vs. MTD, ILMN, WAT, TECH, BIO, BRKR, PACB, HBIO, TMO, and AShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Mettler-Toledo International (MTD), Illumina (ILMN), Waters (WAT), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Charles River Laboratories International vs. Mettler-Toledo International Illumina Waters Bio-Techne Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International (NYSE:MTD) and Charles River Laboratories International (NYSE:CRL) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, community ranking, risk, institutional ownership, earnings and analyst recommendations. Which has preferable valuation and earnings, MTD or CRL? Mettler-Toledo International has higher earnings, but lower revenue than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMettler-Toledo International$3.79B6.85$788.78M$37.0933.18Charles River Laboratories International$4.06B2.34$474.62M$7.9923.25 Do institutionals & insiders believe in MTD or CRL? 95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are held by institutional investors. 1.9% of Mettler-Toledo International shares are held by insiders. Comparatively, 1.3% of Charles River Laboratories International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts recommend MTD or CRL? Mettler-Toledo International presently has a consensus target price of $1,351.25, indicating a potential upside of 9.79%. Charles River Laboratories International has a consensus target price of $214.00, indicating a potential upside of 15.20%. Given Charles River Laboratories International's higher possible upside, analysts plainly believe Charles River Laboratories International is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mettler-Toledo International 1 Sell rating(s) 7 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Charles River Laboratories International 3 Sell rating(s) 10 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.93 Does the media refer more to MTD or CRL? In the previous week, Mettler-Toledo International had 1 more articles in the media than Charles River Laboratories International. MarketBeat recorded 8 mentions for Mettler-Toledo International and 7 mentions for Charles River Laboratories International. Mettler-Toledo International's average media sentiment score of 1.03 beat Charles River Laboratories International's score of 0.77 indicating that Mettler-Toledo International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Charles River Laboratories International 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is MTD or CRL more profitable? Mettler-Toledo International has a net margin of 21.15% compared to Charles River Laboratories International's net margin of 10.44%. Charles River Laboratories International's return on equity of 14.29% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Mettler-Toledo International21.15% -531.78% 24.79% Charles River Laboratories International 10.44%14.29%6.53% Does the MarketBeat Community prefer MTD or CRL? Charles River Laboratories International received 122 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 60.25% of users gave Charles River Laboratories International an outperform vote while only 56.68% of users gave Mettler-Toledo International an outperform vote. CompanyUnderperformOutperformMettler-Toledo InternationalOutperform Votes36956.68% Underperform Votes28243.32% Charles River Laboratories InternationalOutperform Votes49160.25% Underperform Votes32439.75% Which has more volatility and risk, MTD or CRL? Mettler-Toledo International has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, Charles River Laboratories International has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500. SummaryMettler-Toledo International beats Charles River Laboratories International on 10 of the 18 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE ExchangeMarket Cap$9.50B$4.20B$5.13B$19.18BDividend YieldN/A1.78%5.08%3.61%P/E Ratio23.2555.3489.5841.30Price / Sales2.3447.521,116.1217.58Price / Cash11.5223.6242.8221.28Price / Book2.653.144.775.32Net Income$474.62M$139.50M$120.15M$989.88M7 Day Performance-2.46%-0.35%-1.92%-3.54%1 Month Performance-4.42%3.18%11.47%-3.68%1 Year Performance-21.19%14.18%30.54%12.14% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.5242 of 5 stars$185.77+2.0%$214.00+15.2%-19.8%$9.50B$4.06B23.2521,800MTDMettler-Toledo International3.9541 of 5 stars$1,268.03-0.7%$1,351.25+6.6%+3.7%$26.76B$3.76B34.4317,300Positive NewsILMNIllumina4.4832 of 5 stars$143.72-0.1%$165.95+15.5%-0.6%$22.79B$4.39B-14.449,300WATWaters3.7199 of 5 stars$375.89-0.6%$375.850.0%+13.9%$22.32B$2.91B36.097,900TECHBio-Techne4.6346 of 5 stars$76.36+0.9%$82.00+7.4%-3.5%$12.13B$1.17B81.073,100BIOBio-Rad Laboratories4.3519 of 5 stars$339.77+1.0%$394.20+16.0%+6.2%$9.51B$2.58B-12.308,030Analyst RevisionPositive NewsBRKRBruker4.9904 of 5 stars$57.44-0.5%$74.70+30.0%-21.7%$8.71B$2.96B27.759,707Analyst ForecastPACBPacific Biosciences of California1.5488 of 5 stars$2.05+4.6%$2.95+44.1%-79.8%$561.41M$200.52M-1.46730HBIOHarvard Bioscience1.2851 of 5 stars$2.12-1.9%N/A-57.8%$92.47M$97.73M-6.55490TMOThermo Fisher Scientific4.766 of 5 stars$532.06+1.0%$652.30+22.6%+0.9%$203.51B$42.86B33.03122,000AAgilent Technologies4.7188 of 5 stars$137.75-0.9%$143.62+4.3%-2.7%$39.58B$6.51B31.4518,100Analyst ForecastAnalyst Revision Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Illumina Alternatives Waters Alternatives Bio-Techne Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CRL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.